M. Griese, MD, C. Wilnhammer, MD, S. Jansen *, C. Rinker, MD 

Slides:



Advertisements
Similar presentations
The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.
Advertisements

Peter E. Ballmer, MDa, Walter H
Regional differences in tissue oxygenation during cardiopulmonary bypass for correction of congenital heart disease in neonates and small infants: Relevance.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
Yuji Hiramatsu, MDa, Nicolas Gikakis, BSEa, Harry L
Reopro removal during cardiopulmonary bypass using a hemoconcentrator
Peter E. Ballmer, MDa, Walter H
The effect of preoperative methylprednisolone on pulmonary function and pain after lung operations  Dennis Bigler, MDa, Torsten Jonsson, MDa, Johnny Olsen,
Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries 
P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J
Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants  Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,
Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection*  T. Sakuma, MD, H. Kubo, MD, T. Tanita, MD, K.
Changes in the effect of propofol in response to altered plasma protein binding during normothermic cardiopulmonary bypass  E Takizawa, H Hiraoka, D Takizawa,
Steven R. Gundry, MD, Matthew A. Romano, MD, O
Kamal Raissi, MD, Mahmood Meraji, MD, Hassan M. Sadeghi, MD, S. H
Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration  Andreas Günther, MD, Markus Balser,
Shigeyuki Sasaki, MD, PhD (by invitation), James D
The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study  Tomislav Mihaljevic, MDa, Martin.
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Postoperative diaphragmatic hernia after use of the right gastroepiploic artery for coronary artery bypass grafting  Miralem Pasic, MD, PhD, Thierry Carrel,
Hypogammaglobulinemia after cardiopulmonary bypass in infants
Oxygen consumption after cardiopulmonary bypass surgery in children: Determinants and implications  Jia Li, MDa, Ingram Schulze-Neick, MDa, Christopher.
Pulmonary vascular resistance after cardiopulmonary bypass in infants: Effect on postoperative recovery  Ingram Schulze-Neick, MDa, Jia Li, MDa, Daniel.
Effect of esophageal distention on pressure and electromyographic activity of the pharyngoesophageal sphincter, with identification of the esophagopharyngeal.
Increased sensitivity to bradykinin among African Americans
Richard J. Novick, MDa, Ruud A. W
Editorial: The core of leadership
Survival and function after sleeve lobectomy for lung cancer
Pulmonary Surfactant Protein SP-C Counteracts the Deleterious Effects of Cholesterol on the Activity of Surfactant Films under Physiologically Relevant.
Primary repair of rupture of a main and lobar bronchus
Support Your Specialty
Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass 
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Modified Ultrafiltration Improves Left Ventricular Systolic Function In Infants After Cardiopulmonary Bypass  Michael J. Davies, FRCSa, Khan Nguyen, MDa,
Cerebral hyperthermia during cardiopulmonary bypass in adults
Low-potassium dextran solution ameliorates reperfusion injury of the lung and protects surfactant function  Martin Strüber, MDa, Jens M. Hohlfeld, MDb,
A first start for lung transplantation?
Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass  Y. Lamarche, MD, O. Malo, MSc, E. Thorin,
The evolution of intraoperative support in lung transplantation: Cardiopulmonary bypass to extracorporeal membrane oxygenation  P. Michael McFadden, MD,
Get it right the first time
Navigating the lung for hidden treasure
Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins  Peter Holm, MD, Anders Franco-Cereceda,
Release of the cerebral protein S-100 into blood after reperfusion during cardiac operations in infants: Is there a relation to oxygen radical–induced.
David L. Joyce, MD  The Journal of Thoracic and Cardiovascular Surgery 
Kai Ihnken, MD  The Journal of Thoracic and Cardiovascular Surgery 
Increase in size of the pulmonary autograft after the ross operation in children: Growth or dilation?  Laszlo Solymar, MD, PhD, Göran Südow, MD, Daniel.
Ara K. Pridjian, MD, Edward L. Bove, MD, Flavian M. Lupinetti, MD 
Insulin cardioplegia for elective coronary bypass surgery
Nicorandil, a potent adenosine triphosphate–sensitive potassium-channel opener, ameliorates lung allograft reperfusion injury  Motohiro Yamashita, MD,
Cardiac cannulation, sodium and water balance, and ANF plasma levels
The limits of detectable cerebral perfusion by transcranial doppler sonography in neonates undergoing deep hypothermic low-flow cardiopulmonary bypass 
Physiologic left ventricular reconstruction: Shape, function, and time recaptured  Gerald D. Buckberg, MD  The Journal of Thoracic and Cardiovascular Surgery 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Early markers of major adverse events in children after cardiac operations  Trevor Duke, FRACPa, Warwick Butt, FRACPa, Mike South, MD, FRACPb, Tom R. Karl,
Qianli Zhuang, MD, PhD, Bruce Mazer, MD 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
“The more things change…”: The challenges ahead
Short-term neuropsychologic differences after normothermic versus hypothermic cardiopulmonary bypass  Dagmar Buschbeck, Friedrich-Christian Riess, MD,
Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis  William.
M. Ashour, FRCS  The Journal of Thoracic and Cardiovascular Surgery 
Masao Takahashi, MD, Shinichiro Yamamoto, MD, Shigeki Tabata, MD 
Gary E. Hill, MD, FCCMa,b, Anselmo Alonso, MDc, John R
Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD 
Contribution of hyperoxia to lipid peroxidation in coronary artery operations: Should we keep a low oxygen tension?  Leonidas Hadjinikolaou, MD, Andrew.
Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia  Matthias Bauer, MD, Andreas Koster, MD, Miralem Pasic,
A prospective randomized study of neurocognitive function and S-100 protein after antegrade or retrograde brain perfusion with hypothermic arrest for.
Presentation transcript:

Cardiopulmonary bypass reduces pulmonary surfactant activity in infants  M. Griese, MD, C. Wilnhammer, MD, S. Jansen *, C. Rinker, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 118, Issue 2, Pages 237-244 (August 1999) DOI: 10.1016/S0022-5223(99)70213-8 Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 1 Time course of the oxygenation index of the infants treated with CPB. For comparison, values from a control group of infants without lung disease are given. The data from infants 8 and 14, who had a nosocomial infection, were not included. Data are means ± SEM of n different subjects at each time point. *Indicates a difference from the control group (on day 0, P = .043; day 1, P = .023; day 2, P = .009; and day 3, P = .021). The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 2 Total protein in the large-aggregate fraction (LA) (A) and small-aggregate fraction (SA) (B) of the lavage. C, Ratio of protein in small- and large-aggregate (SA/LA) fractions. Comparisons with the control group were made by t test. A, On day 0, P = .028; day 1, P = .002. B, On day 0, P = .033; day 1, P = .004; day 2, P = .001. C, On day 0, P = .032; day 1, P = .004; day 2, P = .008. Data are means ± SEM of n different subjects at each time point. The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 3 Surfactant protein A (SP-A) (A and B ) and surfactant protein B (SP-B) (C and D ) in the large-aggregate fraction (LA) (upper panels) and small-aggregate fraction (SA) (lower panels) of the lavage. Comparisons with the control group were made by t test. A, On day 0, P = .045; day 1, P = .024. B, On day 0, P = .045; C, On day 0, P = .045; day 1, P = .024. D, On day 0, P = .028. Data are means ± SEM of n different subjects at each time point. The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 4 Phospholipids in the large-aggregate fraction (LA) (A) and small-aggregate fraction (SA) (B) of the lavage. C, Ratio of phospholipids in small- and large-aggregate (SA/LA) fractions. Comparisons with the control group were made by t test. A, On day 0, P = .048. B, On day 0, P = .035. Data are means ± SEM of n different subjects at each time point. The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 5 Surface tension of the large-aggregate fraction (LA) in the native state (A and C ) and of its lipid extract (B and D ). Minimal surface tension of the pulsating bubble (γmin ) (A and B ) and of the static bubble after adsorption (γads ) (C and D ). *Indicates a difference from the control group, assessed by t test. A, On day 1, P = .005; day 2, P = .001; day 3, P = .001. Data are means ± SEM of n different subjects at each time point. The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions

Fig. 6 Inhibition of surfactant function by lavage constituents and serum. A natural bovine surfactant (phospholipid concentration 0.25 mg/mL) was mixed with the proteinaceous extract isolated from the large-aggregate fraction (LA) of the lavages of the control infants (filled triangles, n = 4) and of infants 2 to 4 days after CPB (filled squares, n = 11) at a protein concentration of 4 mg/mL. There were no differences between the 2 groups. For comparison, surfactant alone reduced surface tension to low values (open triangles, n = 7). In the presence of normal human serum (protein concentration 4 mg/mL), the surface activity of the natural bovine surfactant was similarly inhibited as in the presence of the material isolated from the lavages (open circles, n = 7). The Journal of Thoracic and Cardiovascular Surgery 1999 118, 237-244DOI: (10.1016/S0022-5223(99)70213-8) Copyright © 1999 Mosby, Inc. Terms and Conditions